LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Novel Microprotein Functions in Messenger RNA Removal Complex

By LabMedica International staff writers
Posted on 15 Dec 2016
Print article
Image: Human kidney cells stained with a P-body marker (red) and NoBody (green). Yellow dots are where P-bodies and NoBody interact. Cell nuclei are shown in blue (Photo courtesy of Yale University).
Image: Human kidney cells stained with a P-body marker (red) and NoBody (green). Yellow dots are where P-bodies and NoBody interact. Cell nuclei are shown in blue (Photo courtesy of Yale University).
A novel "microprotein" has been identified and shown to fulfill a cellular maintenance function by prepping nonessential messenger RNA (mRNA) for destruction and removal from the cytoplasm.

MicroProteins are short single-domain proteins that possess the ability to interfere with larger multi-domain proteins. These protein species can be identified in plants and animals where they evolved from large proteins by successive domain-loss. In previous studies proteomic detection of non-annotated microproteins indicated the translation of hundreds of small open reading frames (smORFs) in human cells, but whether these microproteins had any function was unknown.

Investigators at Yale University (New Haven, CT, USA) located a clutch of microproteins by extracting the large proteins from myeloid leukemia cells and then using liquid chromatography-mass spectroscopy proteomics to determine the amino acid sequences of all remaining small proteins.

They reported in the December 5, 2016, online edition of the journal Nature Chemical Biology that they had identified a 7000 Dalton human microprotein that interacted with mRNA decapping proteins, which remove the 5′ cap from mRNAs to promote 5′-to-3′ decay. Decapping proteins participate in mRNA turnover and nonsense-mediated decay (NMD). The investigators called their novel microprotein "non-annotated P-body dissociating polypeptide" or NoBody.

The investigators found that NoBody localized to mRNA-decay-associated RNA-protein granules called P-bodies. However, the amount of NoBody was not dependent of the number of cellular P-body elements. These results implicated NoBody as a novel component of the mRNA decapping complex and demonstrated the potential functionality of a newly discovered microprotein.

"The broadest significance of this work is that even in a well-studied biological process, a microprotein has been right there under our noses, undetected, all this time," said senior author Dr. Sarah Slavoff, assistant professor of chemistry, molecular biophysics, and biochemistry at Yale University.

Related Links:
Yale University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more